Skip to main content

Table 2 Rate of resistances to SXT, TE, CIP and G among ESBLs and Non ESBL

From: Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania

Isolates

SXT (% R)

TE (% R)

CIP (% R)

G (% R)

Acinetobacter spp (n = 39)

87.2

84.6

43.6

76.9

   Non ESBL (n = 32)

65.6

62.5

25

53

ESBL (n = 7)

100

100

43

100

Escherichia coli (n = 127)

65.4

59.1

33.1

29.1

   Non ESBL (n = 96)

58.3

48.9

23.9

8.3

ESBL (n = 31)

87.1

93.5

61.3

93.5

Klebsiella pneumoniae (n = 91)

48.3

74.7

45

68.1

   Non ESBL (33)

51.5

48.5

6.1

12.1

ESBL (58)

72.4

89.6

20.7

100

Proteus spp (n = 31)

58.4

-

0

16.3

   Non ESBL (29)

55.1

-

0

10.3

ESBL (2)

100.0

-

0

100.0

Other enterobacteria (n = 43)

72

44.2

21

34.8

   Non ESBL (n = 31)

61.3

38.7

12.9

9.6

ESBL (n = 12)

100.0

58.3

41.6

100.0

Pseudomonas spp (n = 46)

97.8

93.5

19.6

34.8

  1. SXT = Sulphamethaxazole/trimethoprim, TE = tetracycline, CIP = ciprofloxacin, and G = Gentamicin